深部热疗在老年食管癌IMRT中的作用:回顾性队列研究
该回顾性队列纳入177例接受IMRT的老年食管癌患者,其中42例联合深部热疗,经倾向评分匹配后比较两组疗效与毒性。结果显示联合热疗组客观缓解率更高(83% vs. 62%,P=0.028),放疗相关毒性更低,但1、2、3年总生存率和无病生存率无显著差异。
要点
- IMRT联合深部热疗可提高老年食管癌患者客观缓解率(83% vs. 62%)。
- 联合热疗组白细胞减少和≥2级放射性肺炎发生率更低。
- 联合热疗未显著改善1、2、3年总生存率和无病生存率。
核心结论
- IMRT联合深部热疗可提高老年食管癌患者客观缓解率并降低放疗相关毒性,但未改善长期生存。
研究设计与样本
- 回顾性队列研究纳入2017至2023年接受IMRT的177例老年食管癌患者,其中42例联合深部热疗。
- 采用倾向评分匹配平衡热放疗组与单纯IMRT组协变量,匹配后每组42例。
主要发现
- 匹配后热放疗组客观缓解率高于单纯IMRT组(83% vs. 62%,P=0.028)。
- 热放疗组白细胞减少发生率更低(14% vs. 33%,P=0.040),≥2级放射性肺炎发生率也更低(P=0.012)。
- 两组1、2、3年总生存率和无病生存率无显著差异(P=0.730、0.964)。
- ≥2级低蛋白血症(OR=3.798,P=0.004)、放疗剂量≤60 Gy(OR=0.445,P=0.006)和下段食管肿瘤(OR=0.387,P=0.005)是总生存的不良预后因素。
- ≥2级低蛋白血症(OR=3.676,P<0.001)也是无病生存的重要预后因素。
关键数值与推荐
- 热放疗组客观缓解率为83%,单纯IMRT组为62%(P=0.028)。
- 热放疗组白细胞减少发生率为14%,单纯IMRT组为33%(P=0.040)。
- ≥2级放射性肺炎发生率组间比较P=0.012。
- 1、2、3年总生存率和无病生存率组间比较P值分别为0.730和0.964。
临床怎么用
- 对于老年食管癌患者,IMRT联合深部热疗可作为提高客观缓解率并降低放疗相关毒性的可行选择。
- 治疗前应关注低蛋白血症等级,≥2级低蛋白血症与更差的总生存和无病生存相关。
局限性
- 本研究为单中心回顾性队列研究,样本量有限。
- 联合热疗未显示长期生存获益,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to assess the clinical utility of deep hyperthermia in elderly patients with esophageal cancer(EC) who underwent intensity-modulated radiotherapy(IMRT). PATIENTS AND METHODS: This retrospective analysis included 177 elderly patients with EC who underwent IMRT between 2017 and 2023, 42 of whom had combined deep hyperthermia (HT). Propensity score matching (PSM) was used to balance the covariates between the thermoradiotherapy (HTRT) group and IMRT-alone groups. Treatment outcomes and toxicities were compared between the two groups. We used the Kaplan-Meier method to estimate survival curves and the log-rank test to compare survival curves. Cox multivariate analysis was performed to analyze the prognostic factors in these patients. RESULTS: After PSM (42 patients in each group), the HTRT group had a greater objective response rate (ORR) than the IMRT-alone group (83% vs. 62%, P = 0.028). The HTRT group had less radiotherapy-related toxicity, including a lower incidence of leukopenia (14% vs. 33%, P = 0.040) and RP grade ≥ 2 (P = 0.012). However, the 1-, 2-, and 3-year overall survival (OS) rates and 1-, 2-, and 3-year disease-free survival (DFS) rates were not significantly different (P = 0.730, 0.964). Grade ≥ 2 hypoproteinemia (odds ratio [OR] = 3.798, P = 0.004), radiotherapy dose ≤ 60 Gy (OR = 0.445, P = 0.006), and tumor location in the lower esophagus (OR = 0.387, P = 0.005) were adverse prognostic factors for OS. Hypoproteinemia grade ≥ 2 (OR = 3.676, P < 0.001) was also a crucial prognostic factor for DFS. CONCLUSION: Adding deep hyperthermia to IMRT can improve the ORR in elderly patients with EC. In addition, it significantly reduces radiotherapy-related toxicity. Although this approach does not improve the long-term prognosis, it is still practical and has low toxicity, making it suitable for clinical use.
引用
- Wang M, Yang J, Wang D, et al. The role of deep hyperthermia in IMRT in elderly patients with esophageal cancer: a retrospective cohort study. Radiat Oncol. 2025. PMID: 40375282. doi:10.1186/s13014-025-02661-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。